Debt-to-equity of Adaptive Biotechnologies Corp from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Adaptive Biotechnologies Corp quarterly Debt-to-equity in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Adaptive Biotechnologies Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 162%, a 24% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Adaptive Biotechnologies Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 162% +31% +24% 30 Sep 2025
Q2 2025 164% +47% +40% 30 Jun 2025
Q1 2025 156% +50% +47% 31 Mar 2025
Q4 2024 144% +47% +49% 31 Dec 2024
Q3 2024 131% +41% +46% 30 Sep 2024
Q2 2024 118% +32% +37% 30 Jun 2024
Q1 2024 106% +30% +39% 31 Mar 2024
Q4 2023 97% +29% +42% 31 Dec 2023
Q3 2023 90% +30% +49% 30 Sep 2023
Q2 2023 86% +32% +60% 30 Jun 2023
Q1 2023 76% +24% +46% 31 Mar 2023
Q4 2022 68% +18% +36% 31 Dec 2022
Q3 2022 61% +11% +22% 30 Sep 2022
Q2 2022 54% +7% +15% 30 Jun 2022
Q1 2022 52% +3% +6% 31 Mar 2022
Q4 2021 50% -1% -2.4% 31 Dec 2021
Q3 2021 50% -4% -7.7% 30 Sep 2021
Q2 2021 47% -12% -20% 30 Jun 2021
Q1 2021 49% -43% -47% 31 Mar 2021
Q4 2020 52% 31 Dec 2020
Q3 2020 54% 30 Sep 2020
Q2 2020 59% 30 Jun 2020
Q1 2020 93% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.